Russian cancer vaccine developer announces tumor success
Full story
A developer of a personalized cancer vaccine in Russia called Neooncovac reports a success. The first patient treated with the vaccine has shown no new tumors for four months.
The first patient treated with Russia’s personalized cancer vaccine Neooncovac has shown no new tumors for four months, its developer says Read Full Article at RT.com